首页> 美国卫生研究院文献>ACS AuthorChoice >Applicationof Quantitative Structure–ActivityRelationship Models of 5-HT1A Receptor Binding toVirtual Screening Identifies Novel and Potent 5-HT1A Ligands
【2h】

Applicationof Quantitative Structure–ActivityRelationship Models of 5-HT1A Receptor Binding toVirtual Screening Identifies Novel and Potent 5-HT1A Ligands

机译:应用结构-活动5-HT1A受体与之结合的关系模型虚拟筛选可识别新型有效的5-HT1A配体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The 5-hydroxytryptamine 1A (5-HT1A) serotonin receptor has been an attractive target for treating mood and anxiety disorders such as schizophrenia. We have developed binary classification quantitative structure–activity relationship (QSAR) models of 5-HT1A receptor binding activity using data retrieved from the PDSP Ki database. The prediction accuracy of these models was estimated by external 5-fold cross-validation as well as using an additional validation set comprising 66 structurally distinct compounds from the World of Molecular Bioactivity database. These validated models were then used to mine three major types of chemical screening libraries, i.e., drug-like libraries, GPCR targeted libraries, and diversity libraries, to identify novel computational hits. The five best hits from each class of libraries were chosen for further experimental testing in radioligand binding assays, and nine of the 15 hits were confirmed to be active experimentally with binding affinity better than 10 μM. The most active compound, Lysergol, from the diversity library showed very high binding affinity (Ki) of 2.3 nM against 5-HT1A receptor. The novel 5-HT1A actives identified with the QSAR-based virtual screeningapproach could be potentially developed as novel anxiolytics or potentialantischizophrenic drugs.
机译:5-羟色胺1A(5-HT1A)血清素受体已成为治疗情绪和焦虑症(如精神分裂症)的有吸引力的靶标。我们已经使用从PDSP Ki数据库中检索到的数据开发了5-HT1A受体结合活性的二元分类定量结构-活性关系(QSAR)模型。这些模型的预测准确性通过外部5倍交叉验证以及使用包含来自World of Molecular Bioactivity数据库的66种结构上不同的化合物的附加验证集进行估算。然后将这些经过验证的模型用于挖掘三种主要类型的化学筛选文库,即类药物文库,GPCR靶向文库和多样性文库,以识别新颖的计算结果。从每一类文库中选择了五个最佳命中值,以进行放射性配体结合测定中的进一步实验测试,并确认了15个命中中的9个在实验上具有活性,结合亲和力优于10μM。来自多样性文库的活性最高的化合物Lysergol对5-HT1A受体显示出2.3 nM的极高结合亲和力(Ki)。通过基于QSAR的虚拟筛选鉴定出的新型5-HT1A活性物质该方法可能被开发为新型抗焦虑药或潜在药物抗精神分裂药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号